Chronic kidney disease (CKD) affects approximately 15% of the U.S. population and Medicare costs exceed $120 billion annually. This science team will develop strategies to improve the health and wellness of CKD patients while realizing tremendous economic impact. Our vision is to optimize the healthcare experience and quality of life (QOL) of individuals with CKD. Technology plays a key role, specifically using VR to increase exercise adherence and nutrition knowledge, and using machine learning to optimize patient-centered fluid management.
Voice of the Patient, Inc.: Consultant and Patient Advocate
University of Illinois at Urbana-Champaign: MD PhD Student, Medicine
Hemodialysis patients routinely experience side effects such as fatigue, lightheadedness and nausea during their treatment sessions. But patients in a study who used a virtual reality program to engage in a mindfulness/meditation exercise reported that these treatment-related symptoms were greatly reduced.
Patients in the study wore a head-mounted virtual reality display to participate in a 25-minute mindfulness/meditation intervention called Joviality, a fully immersive experience that transported them to settings away from the clinic.
The College of Applied Health Sciences has experts in many research areas. Today, we ask KCH professor Ken Wilund about his research on chronic kidney disease and the new Kidney Wellness Institute of Illinois.
VINCE LARA: KCH Professor Ken Wilund has established the Kidney Wellness Institute of Illinois, which is aimed at improving the health and quality life of patients with chronic kidney disease.
School of Social Work professor Rosalba Hernandez is the co-investigator on a newly funded project by the Discovery Partners Institute for the development of the Kidney Wellness Institute of Illinois.
KIWII will bring together local and international leaders in research, medicine, industry, and patient-advocacy to address chronic kidney disease, which affects approximately 15 percent of the U.S. population and costs more than $120 billion a year to treat.